{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:55:30Z","timestamp":1790934930457,"version":"4.1.0"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,3,1]]},"DOI":"10.1086\/381447","type":"journal-article","created":{"date-parts":[[2004,2,23]],"date-time":"2004-02-23T12:24:42Z","timestamp":1077539082000},"page":"S49-S55","source":"Crossref","is-referenced-by-count":34,"title":["Liver Toxicity in Epidemiological Cohorts"],"prefix":"10.1093","volume":"38","author":[{"given":"Stephen","family":"Becker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2004,3,1]]},"reference":[{"key":"key\n\t\t\t\t20171014043743_ref1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.283.1.74","article-title":"Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection","volume":"283","author":"Sulkowski","year":"2000","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20171014043743_ref2","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1097\/00002030-200012220-00011","article-title":"Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection","volume":"14","author":"den Brinker","year":"2000","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20171014043743_ref3","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/00002030-200107060-00007","article-title":"Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy","volume":"15","author":"Martinez","year":"2001","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20171014043743_ref4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/00042560-200108150-00002","article-title":"Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy","volume":"27","author":"Nu\u00f1ez","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20171014043743_ref5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00126334-200110010-00002","article-title":"Low frequency of severe hepatotoxicity and associate with HCV coinfection in HIV-positive patients treated with HAART","volume":"28","author":"Monforte","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20171014043743_ref6","first-page":"379","article-title":"Nevirapine-induced hepatitis: a case series and review of the literature","volume":"7","author":"Pilero","year":"2001","journal-title":"AIDS Reader"},{"key":"key\n\t\t\t\t20171014043743_ref7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00126334-200204010-00003","article-title":"Lack of hepatotoxicity associated with nonnucleoside reverse transcriptase inhibitors","volume":"29","author":"Palmon","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20171014043743_ref8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/jhep.2002.30319","article-title":"Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections","volume":"35","author":"Sulkowski","year":"2002","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20171014043743_ref9","article-title":"Hepatic safety of nevirapine: results of the Boehringer Ingelheim Viramune hepatic safety project [abstract LBOr15]","volume-title":"XIV International AIDS Conference (Barcelona, Spain)","author":"Stern","year":"2002"},{"key":"key\n\t\t\t\t20171014043743_ref10","article-title":"Incidence of hepatotoxicity and mortality in 21 adult antiretroviral treatment trials [abstract 43]","volume-title":"First IAS Conference on HIV Pathogenesis and Treatment (Buenos Aires)","author":"Reisler","year":"2001"},{"key":"key\n\t\t\t\t20171014043743_ref11","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/00002030-199810000-00025","article-title":"Hepatotoxicity after introduction of high active antiretroviral therapy","volume":"12","author":"Rodriguez-Rosado","year":"1998","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20171014043743_ref12","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/00002030-200203290-00009","article-title":"Determinant of recurrent toxicity-driven stitches of high active antiretroviral therapy: the ATHENA cohort","volume":"16","author":"Dieleman","year":"2002","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20171014043743_ref13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1086\/341084","article-title":"Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy","volume":"186","author":"Wit","year":"2002","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014043743_ref14","volume-title":"Table of grading severity of adult adverse experiences","author":"AIDS Clinical Trials Group","year":"1996"},{"key":"key\n\t\t\t\t20171014043743_ref15","article-title":"HIV survival: liver function tests independently predict survival [abstract MoOrB1058]","volume-title":"XIV International AIDS Conference (Barcelona)","author":"Justice","year":"2002"},{"key":"key\n\t\t\t\t20171014043743_ref16","article-title":"Low incidence of grade III\/IV hepatotoxicity in first HAART: observations from 1100 patients followed for 1 year [abstract TuPeB4534]","volume-title":"XIV International AIDS Conference (Barcelona)","author":"Dietrich","year":"2002"},{"key":"key\n\t\t\t\t20171014043743_ref17","article-title":"TARGET: incidence of elevated ALT\/AST with HAART in a large observational cohort [abstract P150]","volume-title":"6th International Congress on Drug Therapy in HIV Infection (Glasgow)","author":"Imperiale","year":"2002"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/38\/Supplement_2\/S49\/20905269\/38-Supplement_2-S49.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T04:37:49Z","timestamp":1507955869000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/38\/Supplement_2\/S49\/330716\/Liver-Toxicity-in-Epidemiological-Cohorts"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,1]]},"references-count":17,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2004,3,1]]},"published-print":{"date-parts":[[2004,3,1]]}},"URL":"https:\/\/doi.org\/10.1086\/381447","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2004,3,1]]},"published":{"date-parts":[[2004,3,1]]}}}